Skip to content
healthcare.dev
Get a free key

Mirabegron

NDC 70518-4304, Mirabegron, tablet, extended release, from REMEDYREPACK INC..

Product NDC
70518-4304
Status
Listed
Labeler
REMEDYREPACK INC.
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA209488
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70518-4304 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • MIRABEGRON50 mg/1

Pharmacologic classes

Adrenergic beta3-Agonists [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]; beta3-Adrenergic Agonist [EPC]

Package NDCNDC-11Package
70518-4304-07051843040090 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70518-4304-0)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/5f7a1758-8691-4e53-96d6-a01626ee8140

Use it

Look up 70518-4304 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70518-4304 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70518-4304. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.